$AUPH
Aurinia Pharmaceuticals Inc.

2024 Q3 Form 10-Q Financial Statement

#000160062024000091 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $67.77M $57.19M
YoY Change 24.32% 37.83%
Cost Of Revenue $6.035M $8.909M
YoY Change -10.84% 469.99%
Gross Profit $61.74M $48.28M
YoY Change 29.3% 20.92%
Gross Profit Margin 91.1% 84.42%
Selling, General & Admin $42.37M $44.93M
YoY Change -11.29% -4.56%
% of Gross Profit 68.63% 93.06%
Research & Development $3.047M $4.080M
YoY Change -77.6% -67.75%
% of Gross Profit 4.94% 8.45%
Depreciation & Amortization $4.893M $4.843M
YoY Change -10.38% 681.13%
% of Gross Profit 7.93% 10.03%
Operating Expenses $3.047M $4.080M
YoY Change -77.6% -92.73%
Operating Profit $11.75M -$1.513M
YoY Change -172.24% -90.64%
Interest Expense $3.059M $1.198M
YoY Change 118.5% -70.32%
% of Operating Profit 26.04%
Other Income/Expense, Net
YoY Change
Pretax Income $14.81M $1.478M
YoY Change -212.61% -112.18%
Income Tax $500.0K $800.0K
% Of Pretax Income 3.38% 54.13%
Net Earnings $14.35M $722.0K
YoY Change -206.72% -106.28%
Net Earnings / Revenue 21.17% 1.26%
Basic Earnings Per Share $0.10 $0.01
Diluted Earnings Per Share $0.10 $0.01
COMMON SHARES
Basic Shares Outstanding 143.0M shares 143.0M shares
Diluted Shares Outstanding 145.7M shares 144.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $348.2M $330.3M
YoY Change 3.3% -5.81%
Cash & Equivalents $36.63M $33.27M
Short-Term Investments $311.6M $297.1M
Other Short-Term Assets $2.700M $6.976M
YoY Change 64.13% -44.37%
Inventory $38.71M $38.85M
Prepaid Expenses $7.840M
Receivables $36.48M $25.52M
Other Receivables $0.00 $0.00
Total Short-Term Assets $440.5M $409.7M
YoY Change 3.28% -1.5%
LONG-TERM ASSETS
Property, Plant & Equipment $2.887M $3.043M
YoY Change -17.42% -97.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $199.0K
YoY Change -100.0%
Other Assets $868.0K $867.0K
YoY Change -42.82% -42.89%
Total Long-Term Assets $108.9M $113.9M
YoY Change -15.28% -14.38%
TOTAL ASSETS
Total Short-Term Assets $440.5M $409.7M
Total Long-Term Assets $108.9M $113.9M
Total Assets $549.4M $523.5M
YoY Change -1.02% -4.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.878M $8.415M
YoY Change -0.25% 75.02%
Accrued Expenses $47.90M $48.35M
YoY Change 8.38% 29.35%
Deferred Revenue $4.304M $4.367M
YoY Change -7.68% 35.29%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.93M $13.91M
YoY Change 12.23% -0.78%
Total Short-Term Liabilities $78.61M $76.90M
YoY Change 6.39% 24.72%
LONG-TERM LIABILITIES
Long-Term Debt $65.96M $64.92M
YoY Change -8.65% -18.26%
Other Long-Term Liabilities $10.80M $10.90M
YoY Change 4.45% -29.79%
Total Long-Term Liabilities $10.80M $10.90M
YoY Change 4.45% -88.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $78.61M $76.90M
Total Long-Term Liabilities $10.80M $10.90M
Total Liabilities $161.4M $158.9M
YoY Change -1.09% 1.47%
SHAREHOLDERS EQUITY
Retained Earnings -$938.0M -$952.3M
YoY Change 2.46% 5.58%
Common Stock $119.8M $112.3M
YoY Change 9.17% 13.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $388.0M $364.6M
YoY Change
Total Liabilities & Shareholders Equity $549.4M $523.5M
YoY Change -1.02% -4.62%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $14.35M $722.0K
YoY Change -206.72% -106.28%
Depreciation, Depletion And Amortization $4.893M $4.843M
YoY Change -10.38% 681.13%
Cash From Operating Activities $17.03M $15.84M
YoY Change -228.33% -660.62%
INVESTING ACTIVITIES
Capital Expenditures $129.0K $84.00K
YoY Change -261.25% -63.0%
Acquisitions
YoY Change
Other Investing Activities -$10.44M -$38.54M
YoY Change -47.2% 616.19%
Cash From Investing Activities -$10.57M -$38.62M
YoY Change -46.34% 588.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.722M -8.273M
YoY Change 16.82% -825.7%
NET CHANGE
Cash From Operating Activities 17.03M 15.84M
Cash From Investing Activities -10.57M -38.62M
Cash From Financing Activities -2.722M -8.273M
Net Change In Cash 3.735M -31.05M
YoY Change -110.58% 325.72%
FREE CASH FLOW
Cash From Operating Activities $17.03M $15.84M
Capital Expenditures $129.0K $84.00K
Free Cash Flow $16.90M $15.76M
YoY Change -228.13% -616.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142984000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142984000 shares
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7840000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9486000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57192000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41494000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107495000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107495000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75903000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75903000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
8909000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1563000 usd
us-gaap Cost Of Revenue
CostOfRevenue
16661000 usd
us-gaap Cost Of Revenue
CostOfRevenue
16661000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1984000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1984000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44934000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47081000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92629000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92629000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97205000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97205000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4080000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12650000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9631000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9631000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25808000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25808000 usd
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
1072000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
us-gaap Restructuring Costs
RestructuringCosts
7755000 usd
us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
290000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3630000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4415000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4415000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3340000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3340000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
58705000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
57664000 usd
us-gaap Costs And Expenses
CostsAndExpenses
122261000 usd
us-gaap Costs And Expenses
CostsAndExpenses
122261000 usd
us-gaap Costs And Expenses
CostsAndExpenses
121657000 usd
us-gaap Costs And Expenses
CostsAndExpenses
121657000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1513000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16170000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14766000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14766000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-45754000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-45754000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
1198000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
65000 usd
us-gaap Interest Expense
InterestExpense
2481000 usd
us-gaap Interest Expense
InterestExpense
2481000 usd
us-gaap Interest Expense
InterestExpense
65000 usd
us-gaap Interest Expense
InterestExpense
65000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4189000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4101000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
8715000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
8715000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7915000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7915000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1478000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12134000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8532000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8532000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37904000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37904000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
756000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-642000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1495000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-206000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
722000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11492000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10027000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10027000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37698000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37698000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-32000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-129000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-129000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
41000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
41000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
717000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11524000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10156000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37657000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143327000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142777000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143507000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142904000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144110000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142777000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143507000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142904000 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
359476000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
383000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
5249000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
703000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8586000 usd
CY2024Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
722000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
364616000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
390408000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
234000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
906000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12268000 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-32000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11492000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
392292000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
377954000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
411000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
18619000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
703000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14323000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-129000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10027000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
364616000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
405435000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1873000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
906000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21735000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
41000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37698000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
392292000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10027000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37698000 usd
us-gaap Depreciation
Depreciation
9690000 usd
us-gaap Depreciation
Depreciation
1436000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6331000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5599000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14323000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21735000 usd
auph Foreign Translation On Finance Lease Liability
ForeignTranslationOnFinanceLeaseLiability
5705000 usd
auph Foreign Translation On Finance Lease Liability
ForeignTranslationOnFinanceLeaseLiability
-417000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-275000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3652000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1433000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6016000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-852000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8403000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4305000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2374000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
12000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
283000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1245000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-365000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-319000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2755000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34496000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
318126000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
256439000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
328877000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
288291000 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
44000 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
11864000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
524000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
96000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
212000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10611000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19252000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
18435000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6001000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1112000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2779000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23324000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2779000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15468000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12465000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48875000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94172000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33407000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81707000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2132000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2713000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1459000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
277000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33265000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81389000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
142000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
318000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33407000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81707000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.25
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers:</span> The Company currently has two main specialty pharmacies for U.S. commercial sales of LUPKYNIS and a collaboration partnership with Otsuka for sales of semi-finished product and royalty, collaboration and manufacturing services revenue in the Otsuka Territories.
auph Concentration Risk Number Of Customers
ConcentrationRiskNumberOfCustomers
2 segment
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
25500000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
24100000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
330674000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
350690000 usd
CY2023Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
350700000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
297300000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
301800000 usd
CY2024Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
330528000 usd
CY2024Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2024Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
53000 usd
CY2024Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
330475000 usd
CY2024Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost
330727000 usd
CY2024Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains
0 usd
CY2024Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses
53000 usd
CY2024Q2 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments
330674000 usd
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
350416000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
74000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
1000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
350489000 usd
CY2023Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost
350616000 usd
CY2023Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains
75000 usd
CY2023Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses
1000 usd
CY2023Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments
350690000 usd
CY2024Q2 us-gaap Interest Receivable
InterestReceivable
600000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
700000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-5000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-129000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-32000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
41000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
500000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
800000 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1702000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1746000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
34224000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
37376000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2927000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
583000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
38853000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
39705000 usd
CY2024Q2 auph Prepaid Assets Current
PrepaidAssetsCurrent
6447000 usd
CY2023Q4 auph Prepaid Assets Current
PrepaidAssetsCurrent
6892000 usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1340000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1345000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
53000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1249000 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7840000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9486000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19942000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15321000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4621000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19846000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14869000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4977000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5264000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5264000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2221000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1910000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3043000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3354000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
400000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
400000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0527
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0619
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6001000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
2172000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
552000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
531000 usd
auph Finance Right Of Use Asset Obtained In Exchange For Lease Obligations
FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations
100845000 usd
auph Finance Right Of Use Asset Obtained In Exchange For Lease Obligations
FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations
117622000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
78829000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
94120000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
8066000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
561000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
16156000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1141000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
16157000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1169000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
16157000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1198000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
16157000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1227000 usd
CY2024Q2 auph Finance Lease Liability To Be Paid Due After Year Four
FinanceLeaseLiabilityToBePaidDueAfterYearFour
20244000 usd
CY2024Q2 auph Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3301000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
92937000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8597000 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
14108000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1443000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
78829000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7154000 usd
CY2024Q2 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
27209000 usd
CY2023Q4 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
16216000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11388000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22486000 usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8415000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4327000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5118000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5190000 usd
CY2024Q2 auph Accrued Research Current
AccruedResearchCurrent
3202000 usd
CY2023Q4 auph Accrued Research Current
AccruedResearchCurrent
5503000 usd
CY2024Q2 auph Restructuring Accruals Current
RestructuringAccrualsCurrent
424000 usd
CY2023Q4 auph Restructuring Accruals Current
RestructuringAccrualsCurrent
0 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
704000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
667000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
56460000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54389000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10900000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10900000 usd
CY2024Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q1 auph Stock Repurchase Program Percentage
StockRepurchaseProgramPercentage
0.15
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3400000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
18600000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
722000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11492000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10027000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37698000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143327000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142777000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143507000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142904000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144110000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142777000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143507000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142904000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0423
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0383
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.131
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.126
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.99
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11556000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
152000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.00
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
85000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1688000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.47
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9935000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.30
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8586000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12268000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14323000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21735000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
32900000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.25
CY2024Q2 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1072000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
7755000 usd

Files In Submission

Name View Source Status
0001600620-24-000091-index-headers.html Edgar Link pending
0001600620-24-000091-index.html Edgar Link pending
0001600620-24-000091.txt Edgar Link pending
0001600620-24-000091-xbrl.zip Edgar Link pending
auph-20240630.htm Edgar Link pending
auph-20240630.xsd Edgar Link pending
auph-2024q2exx311.htm Edgar Link pending
auph-2024q2exx312.htm Edgar Link pending
auph-2024q2exx321.htm Edgar Link pending
auph-2024q2exx322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
auph-20240630_pre.xml Edgar Link unprocessable
auph-20240630_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
auph-20240630_cal.xml Edgar Link unprocessable
auph-20240630_lab.xml Edgar Link unprocessable
auph-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable